busulfan has been researched along with Hyperplasia in 12 studies
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Excerpt | Relevance | Reference |
---|---|---|
"To prolong the survival of patients with chronic myeloid leukemia (CML), 19 patients were treated with busulfan to keep their leukocyte counts within normal range by controlling bone marrow hyperplasia." | 3.67 | [A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan]. ( Atogami, S; Itoyama, T; Jinnai, I; Jubashi, T; Kohno, T; Kuriyama, K; Matsuo, T; Nonaka, H; Tomonaga, M; Tsukasaki, K, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (91.67) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GURELI, N | 1 |
DENHAM, SW | 1 |
ROOT, SW | 1 |
NELSON, BM | 1 |
ANDREWS, GA | 1 |
CAMPANALE, RP | 1 |
Sirois, MG | 1 |
Simons, M | 1 |
Kuter, DJ | 1 |
Rosenberg, RD | 1 |
Edelman, ER | 1 |
Kitahara, M | 1 |
Snover, DC | 1 |
Weisdorf, S | 1 |
Bloomer, J | 1 |
McGlave, P | 1 |
Weisdorf, D | 1 |
Matsuo, T | 1 |
Tomonaga, M | 1 |
Kuriyama, K | 1 |
Jinnai, I | 1 |
Jubashi, T | 1 |
Nonaka, H | 1 |
Kohno, T | 1 |
Tsukasaki, K | 1 |
Atogami, S | 1 |
Itoyama, T | 1 |
Key, NS | 1 |
Kelly, PM | 1 |
Emerson, PM | 1 |
Chapman, RW | 1 |
Allan, NC | 1 |
McGee, JO | 1 |
Reissmann, KR | 1 |
Udupa, KB | 1 |
Kawada, K | 1 |
Kirschner, RH | 1 |
Esterly, JR | 1 |
Rodin, AE | 1 |
Haggard, ME | 1 |
Travis, LB | 1 |
Levine, J | 1 |
Swanson, PD | 1 |
12 other studies available for busulfan and Hyperplasia
Article | Year |
---|---|
Cytologic dysplasia related to busulfan (Myleran) therapy. Report of a case.
Topics: Busulfan; Cervix Uteri; Female; Humans; Hyperplasia; Leukemia; Leukemia, Myeloid | 1963 |
BREAST CANCER AND CYTOLOGIC DYSPLASIA IN MANY ORGANS AFTER BUSULFAN (MYLERAN).
Topics: Breast Neoplasms; Busulfan; Drug Therapy; Humans; Hyperplasia; Leukemia; Leukemia, Myeloid; Neoplasm | 1964 |
PRIMARY THROMBOCYTHEMIA: A SURGICAL PARADOX. REPORT OF A CASE.
Topics: Blood Platelets; Busulfan; Cell Count; Drug Therapy; Hemorrhagic Disorders; Humans; Hyperplasia; Meg | 1964 |
Rat arterial wall retains myointimal hyperplastic potential long after arterial injury.
Topics: Animals; Busulfan; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Hyperplasia; M | 1997 |
Pure RBC aplasia associated with chronic granulocytic leukemia.
Topics: Anemia; Bone Marrow; Busulfan; Erythrocytes; Female; Humans; Hyperplasia; Leukemia, Myeloid; Middle | 1978 |
Nodular regenerative hyperplasia of the liver following bone marrow transplantation.
Topics: Bone Marrow Transplantation; Busulfan; Hepatic Veno-Occlusive Disease; Humans; Hyperplasia; Liver; L | 1989 |
[A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan].
Topics: Adolescent; Adult; Bone Marrow; Busulfan; Female; Humans; Hyperplasia; Leukemia, Myelogenous, Chroni | 1989 |
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Busulfan; Drug Therapy, Combination; Esophageal and Gastric Varices; | 1987 |
Homogeneity of erythropoietin in its effect on self-replication and differentiation of erythropoietin-responsive cells.
Topics: Anemia; Anemia, Aplastic; Animals; Blood; Blood Cells; Busulfan; Cell Differentiation; Cell Division | 1972 |
Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Topics: Adult; Aged; Bronchial Diseases; Busulfan; Epithelium; Female; Humans; Hyperplasia; Leukemia, Myeloi | 1971 |
Lung changes and chemotherapeutic agents in childhood. Report of a case associated with cyclophosphamide therapy.
Topics: Autopsy; Busulfan; Child, Preschool; Cortisone; Cyclophosphamide; Humans; Hyaline Membrane Disease; | 1970 |
Idiopathic thrombocytosis. A treatable cause of transient ischemic attacks.
Topics: Adult; Blood Platelet Disorders; Busulfan; Female; Hemorrhage; Humans; Hyperplasia; Ischemic Attack, | 1968 |